# ScoreItem: LH - Mulheres Fase L√∫tea

**ID:** `019bf31d-2ef0-7a39-b1c5-ae6cf494dacb`
**FullName:** LH - Mulheres Fase L√∫tea (Exames - Laboratoriais)
**Unit:** mIU/mL
**Gender:** female

**Preparation Metadata:**
- Quality Grade: **EXCELLENT**
- Total Chunks: 30 de 14 artigos
- Avg Similarity: 0.614

---

## Contexto

Voc√™ √© um especialista em medicina funcional integrativa e est√° contribuindo com o **Escore Plenya** ‚Äî um escore completo de an√°lise de sa√∫de que avalia todos os aspectos da sa√∫de, performance e longevidade humana. Cada ScoreItem representa um par√¢metro cl√≠nico, laboratorial, gen√©tico, comportamental ou hist√≥rico que comp√µe esse escore.

Seu papel √© gerar conte√∫do cl√≠nico de alta qualidade para enriquecer cada par√¢metro do escore com relev√¢ncia cl√≠nica, orienta√ß√£o ao paciente e conduta pr√°tica.

**Regras inegoci√°veis:**
- Use **apenas** o conhecimento m√©dico real consolidado e os dados presentes nos chunks cient√≠ficos abaixo
- **N√£o alucine, n√£o invente** dados, estudos, estat√≠sticas ou refer√™ncias que n√£o estejam nos chunks ou no seu conhecimento m√©dico estabelecido
- Se um dado espec√≠fico n√£o constar nos chunks e n√£o for do seu conhecimento consolidado, **n√£o o inclua**
- Seja preciso: prefira omitir a inventar

## Instru√ß√£o

Com base nos chunks cient√≠ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `019bf31d-2ef0-7a39-b1c5-ae6cf494dacb`.**

```json
{
  "score_item_id": "019bf31d-2ef0-7a39-b1c5-ae6cf494dacb",
  "clinical_relevance": "Texto t√©cnico para m√©dicos (1000-5000 chars): defini√ß√£o fisiol√≥gica precisa, valores de refer√™ncia e interpreta√ß√£o, fisiopatologia resumida, dados epidemiol√≥gicos com n√∫meros concretos, estratifica√ß√£o de risco baseada em evid√™ncias.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que √© este par√¢metro sem jarg√µes, por que √© importante para a sa√∫de, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta cl√≠nica em Markdown (1000-5000 chars): investiga√ß√£o complementar necess√°ria, crit√©rios de encaminhamento a especialistas, interven√ß√µes baseadas em evid√™ncias. Use bullet points, se√ß√µes e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto cl√≠nico: 1-9 pts
- Alto impacto cl√≠nico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- Crit√©rios: gravidade/mortalidade (40%), preval√™ncia (30%), intervencionabilidade (30%)

---

### Contexto Cient√≠fico

**ScoreItem:** LH - Mulheres Fase L√∫tea (Exames - Laboratoriais)
**Unidade:** mIU/mL
**G√™nero:** female

**30 chunks de 14 artigos (avg similarity: 0.614)**

### Chunk 1/30
**Article:** The inadequate corpus luteum (2021)
**Journal:** Reproduction and Fertility
**Section:** abstract | **Similarity:** 0.759

Estudo revisional sobre a fun√ß√£o do corpo l√∫teo demonstrando que a produ√ß√£o de progesterona l√∫tea √© absolutamente dependente da estimula√ß√£o do receptor de LH/hCG. O LH √© essencial em tr√™s momentos cr√≠ticos: forma√ß√£o do corpo l√∫teo durante a luteiniza√ß√£o folicular, manuten√ß√£o da produ√ß√£o de progesterona durante a fase l√∫tea, e suporte da gravidez inicial at√© que o hCG placent√°rio assuma esta fun√ß√£o. Identificou que corpos l√∫teos inadequados em ciclos naturais refletem desenvolvimento oocit√°rio sub√≥timo ao inv√©s de defeito intr√≠nseco do corpo l√∫teo.

---

### Chunk 2/30
**Article:** Diagnosis and treatment of luteal phase deficiency: a committee opinion (2021)
**Journal:** Fertility and Sterility
**Section:** abstract | **Similarity:** 0.707

Opini√£o de comit√™ da ASRM estabelecendo que progesterona √© secretada em pulsos sob controle do LH, com produ√ß√£o puls√°til pelo corpo l√∫teo em resposta aos pulsos de LH. Os pulsos de progesterona s√£o mais pronunciados nas fases m√©dia e tardia da fase l√∫tea, podendo flutuar at√© 8 vezes dentro de 90 minutos. Valores de progesterona oscilam entre 5 e 40 ng/mL em curtos per√≠odos em mulheres ovulat√≥rias normais. Nenhum teste diagn√≥stico para defici√™ncia de fase l√∫tea provou ser confi√°vel em diferenciar mulheres f√©rteis de inf√©rteis.

---

### Chunk 3/30
**Article:** Progesterone and the Luteal Phase: A Requisite to Reproduction (2015)
**Journal:** Obstetrics and Gynecology Clinics of North America
**Section:** abstract | **Similarity:** 0.681

Estudo abrangente sobre progesterona e fisiologia da fase l√∫tea. Demonstra que o corpo l√∫teo desenvolve-se com neovasculariza√ß√£o imediata resultando em fluxo sangu√≠neo excepcionalmente elevado. C√©lulas l√∫teas diferenciam-se em dois tipos morfol√≥gicos complementares: c√©lulas pequenas contendo receptores de LH regulando capta√ß√£o de colesterol, e c√©lulas grandes com maior capacidade esteroidog√™nica mas sem receptores de LH, conectadas por gap junctions para s√≠ntese coordenada de progesterona. A fase l√∫tea normal dura 11-17 dias (m√©dia 14,2 dias).

---

### Chunk 4/30
**Article:** Identification of the LH surge by measuring intact and total immunoreactivity in urine for prediction of ovulation time (2022)
**Journal:** Hormones (Athens)
**Section:** other | **Similarity:** 0.663

urinary pregnanediol 3-glucuro-
nide to conÔ¨Årm ovulation. Steroids 78(10):1035¬ñ1040
 
18.
 
Ecochard R, Marret H, Rabilloud M, Bradai R, Boehringer H, Girotto S, Barbato M (2000) Sensitivity and speciÔ¨Åcity of ultra-
sound indices of ovulation in spontaneous cycles. Eur J Obstet 
Gynecol Reprod Biol 91(1):59¬ñ64
 
19.
 
Cahill DJ, Wardle PG, Harlow CR, Hull MG (1998) Onset of the preovulatory luteinizing hormone surge: diurnal timing and criti-
cal follicular prerequisites. Fertil Steril 70(1):56¬ñ59
 
20.
 
HoÔ¨Ä JD, Quigley ME, Yen SS (1983) Hormonal dynamics at mid-cycle: a reevaluation. J Clin Endocrinol Metab 57(4):792¬ñ796
 
21.
 
Demir A, Hero M, Alfthan H, Passioni A, Tapanainen JS, and Stenman UH (2022) Intact luteinizing hormone (LH), LHbeta, and 
LHbeta core fragment in urine of menstruating women Minerva 
Endocrinol (Torino). https://
 
doi.
 
org/
 
10.
 
23736/
 
S2724-
 
6507.
 
22.
 
03565-5. Online ahead of print.
 
22.

---

### Chunk 5/30
**Article:** S√≠ndrome dos Ov√°rios Polic√≠sticos - Parte II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.627

; em descend√™ncia asi√°tica, ‚â•4.
- Exames laboratoriais para diferenciais:
  - Prolactina (hiperprolactinemia).
  - 17-OHP (HAC n√£o cl√°ssica).
  - TSH, T4 (¬± T3) para disfun√ß√£o tireoidiana.
  - Testosterona total/livre, DHEA-S (tumores secretores/uso ex√≥geno).
  - USG p√©lvica; RM/TC se suspeita de tumores.
  - S√≠ndrome de Cushing: cortisol salivar noturno ou teste de supress√£o com dexametasona 1 mg (se suspeita cl√≠nica).
- Achados cl√≠nicos gerais:
  - Irregularidade menstrual frequente; ciclos <21 dias, oligomenorreia >35 dias, amenorreia ‚â•3 meses ou <8 menstrua√ß√µes/ano.
  - Sangramento uterino anormal de causa ovulat√≥ria (n√£o estrutural) pode ocorrer.
  - Fen√≥tipo A (tr√™s crit√©rios presentes) com maior risco de complica√ß√µes metab√≥licas.

---

### Chunk 6/30
**Article:** Terapia de Reposi√ß√£o Hormonal Feminina II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.626

tes e fraturas. Recomenda-se o uso de horm√¥nios bioid√™nticos (17-beta-estradiol e progesterona natural micronizada) e a via de administra√ß√£o transd√©rmica para otimizar os resultados e minimizar riscos como tromboembolismo.
## üîñ Pontos de Conhecimento
### 1. Ciclo Menstrual, Climat√©rio e Defici√™ncia Hormonal
*   **Ciclo Menstrual e Produ√ß√£o Hormonal:** O ciclo √© dividido nas fases folicular (predomin√¢ncia de estrog√™nio) e l√∫tea (predomin√¢ncia de progesterona). Todos os horm√¥nios esteroides (estrog√™nios, progesterona, testosterona) derivam do colesterol. A produ√ß√£o ovariana √© explicada pela "teoria das duas c√©lulas", onde as c√©lulas da teca produzem androg√™nios que s√£o convertidos em estrog√™nios nas c√©lulas da granulosa.
*   **Queda Hormonal e Menopausa:** A partir dos 25-30 anos, os n√≠veis hormonais declinam. O climat√©rio √© o per√≠odo de transi√ß√£o, com ciclos irregulares e anovulat√≥rios, sendo o momento ideal para iniciar a TRH.

---

### Chunk 7/30
**Article:** MFI - PROGRAMA√á√ÉO METAB√ìLICA - AULA 03 (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.625

rante a gesta√ß√£o, sem monitorar exames.
    - O palestrante sugere individualiza√ß√£o, mantendo n√≠veis sangu√≠neos acima de 60 ng/mL, idealmente entre 60 e 80 ng/mL, considerando a experi√™ncia do professor Coimbra.
    - Importante acompanhar o PTH, conforme aula da Dra. J√©ssica.
    - Altas doses (ex.: 50.000 UI em um estudo) mostraram melhorar o horm√¥nio antim√ºlleriano e a fertilidade.
    - Revis√µes maiores sugerem ponto de corte de 40 a 60 ng/mL para mulheres com dificuldade de engravidar.
*   **Mio-inositol e melatonina**
    - Ambos podem melhorar a qualidade dos o√≥citos.
    - Mio-inositol melhora a fertilidade principalmente por combater a resist√™ncia perif√©rica √† insulina; dose de 1 a 2 g/dia.
    - Melatonina √© ben√©fica dada a alta preval√™ncia de sono de m√° qualidade e maior estresse oxidativo. Ajustar primeiro a rotina de sono; se necess√°rio, suplementar em doses baixas (sublingual), aumentando progressivamente.

---

### Chunk 8/30
**Article:** Identification of the LH surge by measuring intact and total immunoreactivity in urine for prediction of ovulation time (2022)
**Journal:** Hormones (Athens)
**Section:** other | **Similarity:** 0.620

nduces ovulation within 2¬ñ3days. The surge can be detected 
by the observation of LH in serum or in urine with ovula-
tion predictor kits (OPKs). If a woman knows the duration 
of her menstrual cycle, she can plan the timing of testing. 
The average length of the menstrual cycle is 28days, but 
a regular cycle lasting anywhere between 24 and 38days 
is considered normal [4; 5; 6]. The cycle length is deter-mined by follicular growth and by the lifespan of the corpus 
luteum [7]. Many women experience varying cycle lengths with back and forth shifts in the day of ovulation, which may 
pose a problem especially for infertility patients. To detect 
ovulation, patients are at present required to determine LH 
levels in urine with an OPK daily until getting a positive 
result, which causes undue stress in addition to the Ô¨Ånancial 
burden [8; 9].OPKs may miss the LH surge for various reasons, one being an unusually short cycle.

---

### Chunk 9/30
**Article:** S√≠ndrome dos Ov√°rios Polic√≠sticos - Parte II (2024)
**Journal:** Pos Graduacao MFI
**Section:** introduction | **Similarity:** 0.618

riais espec√≠ficas:
  - Progesterona (dia 21‚Äì24 do ciclo; qualquer dia em amenorreia): >3 ng/mL sugere ovula√ß√£o; >10 ng/mL para manuten√ß√£o da gravidez; alvo 20‚Äì25 ng/mL em contextos selecionados.
- Doses/terapias comentadas:
  - Metformina: pr√°tica cl√≠nica at√© 1.500 mg/dia (XR 500 mg; estudos at√© 1.700 mg/dia); aten√ß√£o √† B12/B6/metilfolato e hiper-homocisteinemia.
  - Inositol: mio-inositol 2 g + √°cido f√≥lico 200 mcg, 2x/dia; associar alfa-lactoalbumina 50 mg, 2x/dia em resistentes.
  - Vitamina D: meta s√©rica 45‚Äì60 ng/mL.
  - Melatonina: 3‚Äì6 mg/noite; benef√≠cios metab√≥licos e antioxidantes.
  - NAC: antioxidante, melhora sensibilidade √† insulina, prote√ß√£o hep√°tica, reduz resist√™ncia a indutores de ovula√ß√£o.
  - √îmega-3 (EPA+DHA): 2‚Äì4 g/dia.
  - Curcumina: 1.000‚Äì2.000 mg/dia com enhancers de biodisponibilidade.
  - Coenzima Q10: suporte √† foliculog√™nese e resposta a indutores.

---

### Chunk 10/30
**Article:** Identification of the LH surge by measuring intact and total immunoreactivity in urine for prediction of ovulation time (2022)
**Journal:** Hormones (Athens)
**Section:** results | **Similarity:** 0.614

or pituitary LH for immunoassay (code 80/552) 
[27]. Total LH concentration is the sum of the concentra-tions of U-LH, U-LH, and U-LHcf; therefore, non-intact 
U-LH concentration was calculated as the arithmetic diÔ¨Äer-ence in concentration between total and intact U-LH.BuÔ¨ÄersTBS buffer contained 0.05mol/L Tris¬ñHCL, pH 7.7, 
0.15mol/L NaCl, and 0.5g/L NaN3. The assay buÔ¨Äer in 
the IFMAs was TBS containing 5g/L bovine serum albu-
min (BSA), 0.5g/L bovine globulin, 0.05g/L Tween 20 
(Sigma-Aldrich), and 20mg/L DTPA. The wash solution 
was obtained from PerkinElmer Wallac, Turku, Finland.StatisticsThe paired-samples t-test was used to analyze diÔ¨Äerences in the ratios of non-intact to intact LH immunoreactivity 
between adjacent days of the menstrual cycle.ResultsFigure1 shows intact and total U-LH-ir during 2weeks before and after the LH surge.

---

### Chunk 11/30
**Article:** Identification of the LH surge by measuring intact and total immunoreactivity in urine for prediction of ovulation time (2022)
**Journal:** Hormones (Athens)
**Section:** results | **Similarity:** 0.610

ateau-type LH peak during several days after the LH 
surge (as in Figs.1 and 2) [33]. However, our results illus-trate that if LH is measured by a method that detects only 
intact LH, the peak concentrations of LH in urine and serum 
occur at the same time (Fig.1). If a method for total LH is used, the peak in urine may be biphasic or broad. A double 
peak of intact LH was not seen in serum, nor was it seen in 
non-intact LH. This suggests that non-intact LH is formed 
in the kidneys and excreted into urine for several days after 
the LH surge.Knowledge regarding the period of high fertility prior to ovulation, which was previously believed to cover the 5days 
prior to ovulation plus the day of ovulation [10; 11; 34; 35; 
36], has been updated.

---

### Chunk 12/30
**Article:** Identification of the LH surge by measuring intact and total immunoreactivity in urine for prediction of ovulation time (2022)
**Journal:** Hormones (Athens)
**Section:** methods | **Similarity:** 0.609

day 
of LH surge based on urinary intact LH, as outlined above. 
For each participant, days were numbered according to the 
number of days before (
 
‚àí) and after (
 
+) the LH surge. The women did not receive any medication 3months prior to 
and during the study, including hormonal contraceptives and 
hormonal intrauterine devices. Serum samples were stored 
at
 
‚àí
 
20¬∞C, and, based on our earlier Ô¨Åndings, urine samples were stored at 4¬∞C for less than 1week before assayed.ImmunoÔ¨Çuorometric assaysThe immunoÔ¨Çuorometric methods (IFMAs) are commercial 
sandwich assays using monoclonal antibodies (LH DelÔ¨Åa¬Æ 
and LHspec DelÔ¨Åa¬Æ, PerkinElmer Wallac, Turku, Finland). 
One antibody is immobilized onto a microtiter strip well and 
the other is labeled with a europium chelate. In the assay 
for intact LH, the capture antibody is speciÔ¨Åc for LH and 
the detection antibody for the -subunit.

---

### Chunk 13/30
**Article:** Anatomy, Abdomen and Pelvis, Ovary Corpus Luteum (2023)
**Journal:** StatPearls
**Section:** abstract | **Similarity:** 0.608

Revis√£o anat√¥mica e fisiol√≥gica do corpo l√∫teo demonstrando que esta estrutura end√≥crina tempor√°ria desenvolve-se ap√≥s ovula√ß√£o a partir de c√©lulas da teca e granulosa foliculares. O corpo l√∫teo regula o eixo hipot√°lamo-hipofis√°rio atrav√©s da inibi√ß√£o de GnRH, diminuindo consequentemente a libera√ß√£o de LH e FSH pela hip√≥fise anterior. Persiste por aproximadamente 14 dias p√≥s-ovula√ß√£o se n√£o houver fertiliza√ß√£o, degenerando em corpus albicans. Secreta progesterona, inibina A e estradiol durante sua fase funcional.

---

### Chunk 14/30
**Article:** Physiology, Follicle Stimulating Hormone (2023)
**Journal:** StatPearls [Internet]
**Section:** abstract | **Similarity:** 0.602

Comprehensive review of FSH physiology detailing its role throughout the menstrual cycle. The article explains that FSH reaches peak levels simultaneously with the LH surge that triggers ovulation. During the follicular phase, when a dominant follicle produces sufficient estradiol (200-300 pg/ml for 48 hours), the hypothalamus responds with a GnRH surge stimulating FSH secretion. The review covers clinical applications including fertility assessment, PCOS diagnosis, ovarian reserve evaluation, and therapeutic uses in assisted reproduction.

---

### Chunk 15/30
**Article:** Defining the LH surge in natural cycle frozen-thawed embryo transfer: the role of LH, estradiol, and progesterone (2025)
**Journal:** Journal of Ovarian Research
**Section:** abstract | **Similarity:** 0.601

Study of 668 natural cycle FET examining precise hormonal changes during the LH surge. Findings showed that successful ovulation involves simultaneous LH increase (>180% baseline), estradiol decrease, and progesterone rise (threefold increase). Patients who conceived showed significantly higher progesterone increases. The research emphasizes the importance of monitoring multiple hormones, including FSH context, for optimal fertility timing and embryo transfer success (52-56.8% pregnancy rates).

---

### Chunk 16/30
**Article:** Identification of the LH surge by measuring intact and total immunoreactivity in urine for prediction of ovulation time (2022)
**Journal:** Hormones (Athens)
**Section:** results | **Similarity:** 0.599

rious forms of LH.Our results show that an OPK detecting total or non-intact U-LH-ir will be strongly positive for up to 3days after the 
peak for intact U-LH-ir, which is positive for only a single day 
during the LH surge. Therefore, the likelihood of detecting 
the fertility window within and beyond the LH surge period 
should be greater if an OPK detecting total U-LH-ir rather 
than intact LH is used. The best alternative may be to use 
an OPK detecting both intact and non-intact U-LH-ir sepa-
rately, the latter preferably in the form of LHcf. An OPK that 
detects total and intact LH-ir can function as a compromise 
solution by calculating the non-intact LH-ir as the arithmetic 
diÔ¨Äerence.

---

### Chunk 17/30
**Article:** Identification of the LH surge by measuring intact and total immunoreactivity in urine for prediction of ovulation time (2022)
**Journal:** Hormones (Athens)
**Section:** other | **Similarity:** 0.599

ne of menstruating women Minerva 
Endocrinol (Torino). https://
 
doi.
 
org/
 
10.
 
23736/
 
S2724-
 
6507.
 
22.
 
03565-5. Online ahead of print.
 
22.
 
Pettersson K, Ding YQ, Huhtaniemi I (1992) An immunologically anomalous luteinizing hormone variant in a healthy woman. J Clin 
Endocrinol Metab 74(1):164¬ñ171
 
23.
 
Pettersson KS, Soderholm JR (1991) Individual diÔ¨Äerences in lutropin immunoreactivity revealed by monoclonal antibodies. 
Clin Chem 37(3):333¬ñ340
 
24.
 
Pettersson K, Ding YQ, Huhtaniemi I (1991) Monoclonal anti-body-based discrepancies between two-site immunometric tests 
for lutropin. Clin Chem 37(10 Pt 1):1745¬ñ1748
 
25.
 
Stenman UH, Alfthan H (2013) Determination of human cho-rionic gonadotropin. Best Pract Res Clin Endocrinol Metab 
27(6):783¬ñ793
 
26.

---

### Chunk 18/30
**Article:** Identification of the LH surge by measuring intact and total immunoreactivity in urine for prediction of ovulation time (2022)
**Journal:** Hormones (Athens)
**Section:** other | **Similarity:** 0.598

man pituitary 
extracts. Endocrinology 133(3):985¬ñ989
 
2.
 
Kovalevskaya G, Birken S, O¬íConnor J, Schlatterer J, Maydel-man Y, CanÔ¨Åeld R (1995) HLH beta core fragment immunore-
activity in the urine of ovulating women: a sensitive and speciÔ¨Åc 
immunometric assay for its detection. Endocrine 3(12):881¬ñ887
 
3.
 
Iles RK, Lee CL, Howes I, Davies S, Edwards R, Chard T (1992) Immunoreactive beta-core-like material in normal 
419
Hormones (2022) 21:413‚Äì420

postmenopausal urine: human chorionic gonadotrophin or LH origin? Evid Existence LH Core J Endocrinol 133(3):459¬ñ466
 
4.
 
Fraser IS, Critchley HO, Munro MG, Broder M (2007) Can we achieve international agreement on terminologies and deÔ¨Å-
nitions used to describe abnormalities of menstrual bleeding? 
Hum Reprod 22(3):635¬ñ643
 
5.
 
Mihm M, Gangooly S, Muttukrishna S (2011) The normal men-strual cycle in women. Anim Reprod Sci 124(3¬ñ4):229¬ñ236
 
6.

---

### Chunk 19/30
**Article:** Fisiologia End√≥crina Feminina (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.598

h√° exame f√≠sico, laboratoriais ou de imagem de uma paciente espec√≠fica. S√£o apresentados conceitos fisiol√≥gicos e dados t√©cnicos:
  - Menopausa: diagn√≥stico retrospectivo ap√≥s 12 meses de amenorreia; data definida pela √∫ltima menstrua√ß√£o. Idade m√©dia no Brasil ~51 anos; irregularidade de ciclos por volta de 45‚Äì46 anos.
  - Reserva ovariana:
    - Queda quantitativa e qualitativa dos fol√≠culos ovarianos com a idade (maior perda entre 30‚Äì40 anos; aos 50 anos ~70% dos fol√≠culos de baixa qualidade).
    - Horm√¥nio Anti-M√ºlleriano (AMH) declina com a idade; exemplos:
      - AMH 0,14 ng/mL aos 32 anos ~ percentil 5; menopausa m√©dia predita ~48 anos (faixa ~42‚Äì53).
      - Regra pr√°tica em reprodu√ß√£o assistida: AMH x 10 ‚âà n√∫mero esperado de fol√≠culos por ciclo (ex.: 0,1 ‚Üí ~1 fol√≠culo).

---

### Chunk 20/30
**Article:** Identification of the LH surge by measuring intact and total immunoreactivity in urine for prediction of ovulation time (2022)
**Journal:** Hormones (Athens)
**Section:** methods | **Similarity:** 0.597

pproxi-
mately 1¬ñ2days (oocyte lifespan) after ovulation [18]. Onset 
of the LH surge precedes ovulation by 35¬ñ44h, and the peak 
level of serum LH (S-LH) precedes ovulation by 10¬ñ12h 
[19; 20]. Pregnancy rates are highest from 2days before 
ovulation to the day of ovulation [9].We have recently described methods for separation and determination of three molecular forms of LH immunoreac-
tivity (LH-ir), namely, intact LH, its free beta-subunit (LH), 
and LHcf. The latter two together form the non-intact por-tion of the LH-ir. The three forms can be separated by gel 
Ô¨Åltration of urine obtained from regularly menstruating 
women, LHcf being the dominant form among degrada-
tion products of LH subsequent to the LH surge [21].In the current study, we have examined whether speciÔ¨Åc detection of the various forms of LH in urine can improve 
detection of the LH surge.

---

### Chunk 21/30
**Article:** MFI - PROGRAMA√á√ÉO METAB√ìLICA - AULA 03 (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.594

de √°cidos graxos √¥mega-3.
## Objetivo:
Aus√™ncia de dados objetivos de exame cl√≠nico individual (sem sinais vitais, exame f√≠sico, exames laboratoriais espec√≠ficos, nem imagens). S√£o citados estudos e recomenda√ß√µes gerais:
- Antioxidantes alimentares (luteolina, licopeno, lupiol, √°cido betul√≠nico) e resveratrol com poss√≠veis efeitos na fertilidade; preferir fontes alimentares; poss√≠vel exce√ß√£o para resveratrol em endometriose.
- Vitamina D: discuss√£o de doses altas (ex.: 10.000 UI/dia na gesta√ß√£o por opini√£o de especialista; estudos com dose de ataque de 50.000 UI elevando AMH); alvo sugerido 40‚Äì60 ng/mL, possivelmente 60‚Äì80 ng/mL; acompanhar PTH.
- Inositol (provavelmente mio-inositol) 1‚Äì2 g/dia e melatonina (dose individual, preferir sublingual, iniciar baixo) para melhorar qualidade dos o√≥citos, especialmente com resist√™ncia √† insulina e sono inadequado.

---

### Chunk 22/30
**Article:** Identification of the LH surge by measuring intact and total immunoreactivity in urine for prediction of ovulation time (2022)
**Journal:** Hormones (Athens)
**Section:** discussion | **Similarity:** 0.594

Goldsmith LT, Skurnick JH, Wojtczuk A, Weiss G (2007) Characteristics of the urinary luteinizing hormone surge in young 
ovulatory women. Fertil Steril 88(3):684¬ñ690
 
34.
 
Dunson DB, Baird DD, Wilcox AJ, Weinberg CR (1999) Day-spe-ciÔ¨Åc probabilities of clinical pregnancy based on two studies with 
imperfect measures of ovulation. Hum Reprod 14(7):1835¬ñ1839
 
35.
 
Schwartz D, Macdonald PD, and Heuchel V (1980) Fecundabil-ity, coital frequency and the viability of ova Popul Stud (Camb) 
34(2):397¬ñ400
 
36.
 
Temporal relationships between ovulation and deÔ¨Åned changes in the concentration of plasma estradiol-17 beta, luteinizing hor-mone, follicle-stimulating hormone, and progesterone. I. Probit 
analysis. World Health Organization, Task Force on Methods for 
the Determination of the Fertile Period, Special Programme of 
Research, Development and Research Training in Human Repro-
duction (1980) Am J Obstet Gynecol 138(4):383¬ñ390
 
37.

---

### Chunk 23/30
**Article:** Proliferative and Follicular Phases of the Menstrual Cycle (2022)
**Journal:** StatPearls Publishing
**Section:** abstract | **Similarity:** 0.587

Artigo descritivo sobre a fase folicular e proliferativa do ciclo menstrual feminino. Explica o processo de matura√ß√£o dos fol√≠culos ovarianos durante a fase folicular, preparando-os para libera√ß√£o na ovula√ß√£o. Aborda mudan√ßas endometriais concomitantes e a import√¢ncia cl√≠nica da fase folicular inicial para avalia√ß√£o de reserva ovariana e fun√ß√£o reprodutiva. Inclui correla√ß√µes com n√≠veis hormonais e aplica√ß√µes diagn√≥sticas.

---

### Chunk 24/30
**Article:** The Effect of Spontaneous LH Surges on Pregnancy Outcomes in Patients Undergoing Letrozole-HMG IUI: A Retrospective Analysis of 6,285 Cycles (2022)
**Journal:** Frontiers in Endocrinology
**Section:** results | **Similarity:** 0.585

ontiersin.orgMay2022|Volume13|Article8805386

ItwassuggestedinourstudythataspontaneousLHsurgemightnotbeassociatedwiththeectopicpregnancy,whileleadfollicleswithin14.1-16.0mmwereprobablyrelatedtoahigherriskofectopicpregnancy.Sofar,limitedliteraturefocusingon
thesetwotopicsisavailable.Therefore,weareamongthersttoreporttherelationshipsbetweenaspontaneousLHsurge/follicle
sizeandtheectopicpregnancy,theunderlyingmechanismof
whichawaitsfurtherexploration.AnotherintriguingndingwasthatitseemedthattheshortertheLEtreatment,thehighertheriskofectopicpregnancy.Asisknown,LEinhibitsthesynthesis
ofestrogen,resultinginasignicantlylowerE2level.Accordingtosomestudies,ectopicpregnancywassignicantlyhigherinstimulatedcyclesortwo-follicleHMGcycles,comparedwith
naturalcyclesforIUIcycles(17,18).MeanwhileanotherstudyshowedthattherateofectopicpregnancyincreasedwiththepeakE2levelforin-vitrofertilization(IVF)/intracytoplasmicsperminjection(ICSI)cycles(19).AlloftheseresultsIndicatethatthetubal-uterineenvironmenta

---

### Chunk 25/30
**Article:** MFI - PROGRAMA√á√ÉO METAB√ìLICA - AULA 03 (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.585

escrever prasterona (DHEA) 25‚Äì50 mg por curto per√≠odo se S-DHEA estiver baixo, monitorando.
    - Confirmada a gravidez, interromper prasterona/DHEA e testosterona.
    - Progesterona (ex.: Utrogestan 100 mg vaginal) do 15¬∫ ao 24¬∫ dia do ciclo pode aumentar chances de gravidez em mulheres >30 anos ou com pico inadequado; se houver gravidez, o obstetra pode recomendar continuar nos primeiros meses.
### 2. √îmega-3 e Programa√ß√£o Metab√≥lica
*   **Import√¢ncia do √¥mega-3 na gesta√ß√£o**
    - A dieta moderna √© desproporcionalmente rica em √¥mega-6 (√≥leos de soja, canola, milho), tornando o √¥mega-3 (especialmente DHA) crucial.
    - DHA √© fundamental para o desenvolvimento neurol√≥gico fetal, com alta concentra√ß√£o no c√©rebro do feto.
    - Suplementa√ß√£o de √¥mega-3 na gesta√ß√£o pode reduzir risco de parto prematuro e alergias na inf√¢ncia, al√©m de aumentar modestamente o peso ao nascer.

---

### Chunk 26/30
**Article:** The Effect of Spontaneous LH Surges on Pregnancy Outcomes in Patients Undergoing Letrozole-HMG IUI: A Retrospective Analysis of 6,285 Cycles (2022)
**Journal:** Frontiers in Endocrinology
**Section:** discussion | **Similarity:** 0.582

2022)TheEffectofSpontaneousLHSurgesonPregnancyOutcomesinPatientsUndergoingLetrozole-HMGIUI:ARetrospectiveAnalysisof6,285Cycles.Front.Endocrinol.13:880538.doi:10.3389/fendo.2022.880538
ORIGINALRESEARCHpublished:04May2022doi:10.3389/fendo.2022.880538

Conclusions:ThepresenceofaspontaneousLHsurgeintriggeredLE-HMGIUIcyclesdoesnotappeartoimprovepregnancyrates.Thus,wesuggestthatwaitingforanLH
surgetooccurisnotnecessaryintriggeredLE-HMGIUIcycles.Keywords:intrauterineinsemination,letrozole,spontaneousLHsurge,clinicalpregnancyrate,infertilityBACKGROUNDIntrauterineinsemination(IUI)isconsideredasarst-linetreatmentforinfertility,includingabroadrangeofindications
(1,2).Combiningovarianstimulation(OS)withIUIhasbeenproventobeaneffectivemethod.In2018,areviewconcludedthat
ithadbecomeclearthatIUI‚ÄìOSisarst-linetreatmentoptionformildmaleandunexplainedinfertility(3).Furthermore,arecentsystematicreviewin2020claimedanddemonstratedthattreatmentwithIUI-OSprobablyresultedinahighercumulative
livebirthratecom

---

### Chunk 27/30
**Article:** Identification of the LH surge by measuring intact and total immunoreactivity in urine for prediction of ovulation time (2022)
**Journal:** Hormones (Athens)
**Section:** conclusion | **Similarity:** 0.582

t of the U-LH-ir consisted of LHcf and it remained strongly 
elevated (over Ô¨Åvefold compared to intact LH) for the Ô¨Årst 3days after the LH surge, moderately elevated (over threefold) 
thereafter until day
 
+
 
5, and mildly elevated until day
 
+
 
7.Conclusions
 
Total and non-intact LH-ir are potential add-on characteristics which can be utilized in ovulation predictor kits to measure LH-ir in urine beyond the LH surge during a broader time frame, thereby paving the way for more precise 
prediction of the timing of ovulation than that obtained with currently available products.Keywords
 
Urinary¬∑ Luteinizing hormone¬∑ Gonadotropin¬∑ Menstruation¬∑ Ovulation¬∑ Fertility¬∑ Infertility¬∑ Ovulation predictor kitAbbreviationsFSH
  
Follicle-stimulating hormonehCG
  
Human chorionic gonadotropinhCGcf
  
Core fragment of human chorionic gonadotropinIFMA
  
ImmunoÔ¨Çuorometric assayLH
  
Luteinizing hormoneLH-ir
  
LH immunoreactivityLH
  
Beta subunit of luteinizing hormone

---

### Chunk 28/30
**Article:** The Effect of Spontaneous LH Surges on Pregnancy Outcomes in Patients Undergoing Letrozole-HMG IUI: A Retrospective Analysis of 6,285 Cycles (2022)
**Journal:** Frontiers in Endocrinology
**Section:** other | **Similarity:** 0.582

489-4.039)0.528RankofIUIattempts(1stvs.3rd)0.000(0.000-.)0.994Durationofinfertility(years)0.793(0.575-1.094)0.1575,000IUhCGvs.0.1mgGnRHa0.693(0.237-2.024)0.5025,000IUhCGvs.5,000IUhCG+0.1mgGnRHa0.000(0.000-.)0.993
Folliclesize(14.1-16.0vs.16.1-18.0mm)0.114(0.009-1.402)0.090Folliclesize(14.1-16.0vs.18.1-20.0mm)0.142(0.023-0.891)0.037*Folliclesize(14.1-16.0vs.20.1-22.0mm)0.142(0.022-0.903)0.039*Trigger+LHsurgevs.triggeronly0.428(0.098-1.869)0.259Trigger+LHsurgevs.LHsurgeonly1.178(0.000-.)1.000CI,condenceinterval;OR,oddsratio.*P<0.05.
Jiangetal.LHSurgeinLE-HMG-IUICycles
FrontiersinEndocrinology|www.frontiersin.orgMay2022|Volume13|Article8805387

spontaneousLHsurgescomparedtoRCTs.ThereasonbehindthisisthatitisimpossibletopredictwhenanLHsurgewilloccur
andwhetherthereisgoingtobeanLHsurgeatall.Secondly,the
sizeoftheleadfolliclesmightbeaffectedduetotheprolonged
waitingforanLHsurge,whichmightbeaconfoundingfactor.

---

### Chunk 29/30
**Article:** Physiology, Follicle Stimulating Hormone (2024)
**Journal:** StatPearls
**Section:** abstract | **Similarity:** 0.581

Comprehensive review of FSH physiology across the menstrual cycle including luteal phase FSH dynamics.

---

### Chunk 30/30
**Article:** The Effect of Spontaneous LH Surges on Pregnancy Outcomes in Patients Undergoing Letrozole-HMG IUI: A Retrospective Analysis of 6,285 Cycles (2022)
**Journal:** Frontiers in Endocrinology
**Section:** other | **Similarity:** 0.580

)1.012(0.991-1.033)0.273TriggerdayLHlevel(mIU/ml)1.006(0.962-1.052)0.800TriggerdayPlevel(ng/ml)0.713(0.137-3.712)0.688Endometrialthicknessattriggering(mm)1.013(0.800-1.282)0.916No.ofleadfollicles(1vs.2)5.203(0.450-60.223)0.187No.ofleadfollicles(1vs.3)14.917(0.370-602.077)0.152
Femaleage(years)1.106(0.890-1.375)0.363Maleage(years)0.995(0.840-1.179)0.957FemaleBMI(kg/m2)1.003(0.884-1.139)0.958MaleBMI(kg/m2)0.992(0.849-1.159)0.915Infertilitytype(primaryvs.secondary)1.573(0.534-4.631)0.411Infertilitycause(ovulatorydysfunctionvs.sexualdysfunction)0.705(0.062-8.069)0.779Infertilitycause(ovulatorydysfunctionvs.malefactor)0.397(0.039-4.060)0.436
Infertilitycause(ovulatorydysfunctionvs.unexplainedfactor)0.699(0.174-2.805)0.614Antralfollicles1.036(0.966-1.110)0.323RankofIUIattempts(1stvs.2nd)1.405(0.489-4.039)0.528RankofIUIattempts(1stvs.3rd)0.000(0.000-.)0.994Durationofinfertility(years)0.793(0.575-1.094)0.1575,000IUhCGvs.0.1mgGnRHa0.693(0.237-2.024)0.5025,000IUhCGvs.5,000IUhCG+0.1mgGnRHa0.000(0

---

